Nuvectis Pharma, Inc. NVCT Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $25.13M-20.6% | $31.63M-10.7% | $35.44M+32.3% | $26.79M-10.3% | $29.86M+61.1% | ||
| $268K+257% | $75K-48.3% | $145K-32.2% | $214K-24.6% | $284K+284% | ||
| $25.4M-19.9% | $31.71M-10.9% | $35.59M+31.8% | $27.01M-10.4% | $30.15M+62.0% | ||
| $25.4M-19.9% | $31.71M-10.9% | $35.59M+31.8% | $27.01M-10.4% | $30.15M+62.0% | ||
| $4.7M-25.2% | $6.27M-2.6% | $6.44M+29.4% | $4.98M+66.3% | $2.99M+19.8% | ||
| $6.45M-6.7% | $6.91M+38.2% | $5M-1.6% | $5.08M+0.9% | $5.04M-9.3% | ||
| $11.18M-15.9% | $13.3M+14.8% | $11.58M+14.2% | $10.14M+10.2% | $9.19M+3.4% | ||
| $11.18M-15.9% | $13.3M+14.8% | $11.58M+14.2% | $10.14M+10.2% | $9.19M+3.4% | ||
| $119.96M+1.6% | $118.1M+1.5% | $116.38M+14.3% | $101.78M+2.3% | $99.53M+20.0% | ||
| -$105.74M-6.1% | -$99.69M-7.9% | -$92.37M-8.8% | -$84.91M-8.1% | -$78.58M-7.3% | ||
| $14.22M-22.8% | $18.41M-23.3% | $24.01M+42.3% | $16.87M-19.5% | $20.95M+116% | ||
| $25.4M-19.9% | $31.71M-10.9% | $35.59M+31.8% | $27.01M-10.4% | $30.15M+62.0% | ||
| $268K+257% | $75K-48.3% | $145K-32.2% | $214K-24.6% | $284K+284% | ||
| $6.45M-6.7% | $6.91M+38.2% | $5M-1.6% | $5.08M+0.9% | $5.04M-9.3% | ||
| $36K-68.7% | $115K+76.9% | $65K+3,150% | $2K-99.8% | $865K+3.0% | ||
| $36K-68.7% | $115K+76.9% | $65K+3,150% | $2K-99.8% | $865K+3.0% | ||
| $6.45M-6.7% | $6.91M+38.2% | $5M-1.6% | $5.08M+0.9% | $5.04M-9.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nuvectis Pharma, Inc.'s total assets?
- Nuvectis Pharma, Inc. (NVCT) holds $25.4M in total assets, down 15.8% year over year.
- How much cash does Nuvectis Pharma, Inc. have?
- Nuvectis Pharma, Inc. holds $25.1M in cash and equivalents.
- Can Nuvectis Pharma, Inc. cover its short-term obligations?
- Its current ratio is 2.27 — current assets exceed current liabilities.
- Where does Nuvectis Pharma, Inc.'s balance sheet data come from?
- Every line is extracted from Nuvectis Pharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.